Mega Lifesciences Public Company Limited (MEGA.BK)
THB 32.75
(0.0%)
THB 32.75
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 5.21 Billion THB | -11.12% |
| 2022 | 5.86 Billion THB | 11.88% |
| 2021 | 5.24 Billion THB | 13.79% |
| 2020 | 4.61 Billion THB | 5.81% |
| 2019 | 4.35 Billion THB | 11.5% |
| 2018 | 3.9 Billion THB | 12.45% |
| 2017 | 3.47 Billion THB | 6.57% |
| 2016 | 3.26 Billion THB | -0.51% |
| 2015 | 3.27 Billion THB | 19.45% |
| 2014 | 2.74 Billion THB | -3.49% |
| 2013 | 2.84 Billion THB | 13.32% |
| 2012 | 2.5 Billion THB | 27.26% |
| 2011 | 1.97 Billion THB | 43.82% |
| 2010 | 1.37 Billion THB | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 5.39 Billion THB | 16.38% |
| 2024 Q1 | 4.63 Billion THB | -11.15% |
| 2023 Q4 | 5.21 Billion THB | -9.64% |
| 2023 FY | 5.21 Billion THB | -11.12% |
| 2023 Q1 | 5.49 Billion THB | -6.32% |
| 2023 Q3 | 5.77 Billion THB | 3.06% |
| 2023 Q2 | 5.6 Billion THB | 1.88% |
| 2022 Q2 | 5.97 Billion THB | 19.01% |
| 2022 Q3 | 5.54 Billion THB | -7.19% |
| 2022 Q1 | 5.01 Billion THB | -4.32% |
| 2022 FY | 5.86 Billion THB | 11.88% |
| 2022 Q4 | 5.86 Billion THB | 5.87% |
| 2021 Q1 | 4.1 Billion THB | -10.87% |
| 2021 FY | 5.24 Billion THB | 13.79% |
| 2021 Q4 | 5.24 Billion THB | 3.81% |
| 2021 Q3 | 5.05 Billion THB | 14.99% |
| 2021 Q2 | 4.39 Billion THB | 6.95% |
| 2020 Q2 | 4.81 Billion THB | -2.3% |
| 2020 Q1 | 4.93 Billion THB | 13.2% |
| 2020 FY | 4.61 Billion THB | 5.81% |
| 2020 Q3 | 5.03 Billion THB | 4.54% |
| 2020 Q4 | 4.61 Billion THB | -8.48% |
| 2019 Q3 | 4.39 Billion THB | 2.89% |
| 2019 Q4 | 4.35 Billion THB | -0.87% |
| 2019 Q1 | 3.95 Billion THB | 1.11% |
| 2019 Q2 | 4.27 Billion THB | 8.12% |
| 2019 FY | 4.35 Billion THB | 11.5% |
| 2018 FY | 3.9 Billion THB | 12.45% |
| 2018 Q4 | 3.9 Billion THB | 18.16% |
| 2018 Q3 | 3.3 Billion THB | -0.48% |
| 2018 Q2 | 3.32 Billion THB | 10.03% |
| 2018 Q1 | 3.02 Billion THB | -13.09% |
| 2017 Q1 | 2.98 Billion THB | -8.38% |
| 2017 Q4 | 3.47 Billion THB | 0.8% |
| 2017 Q3 | 3.44 Billion THB | 4.04% |
| 2017 Q2 | 3.31 Billion THB | 10.91% |
| 2017 FY | 3.47 Billion THB | 6.57% |
| 2016 Q4 | 3.26 Billion THB | 6.03% |
| 2016 FY | 3.26 Billion THB | -0.51% |
| 2016 Q1 | 2.87 Billion THB | -12.25% |
| 2016 Q2 | 2.87 Billion THB | -0.19% |
| 2016 Q3 | 3.07 Billion THB | 7.13% |
| 2015 Q3 | 3.2 Billion THB | 7.05% |
| 2015 Q4 | 3.27 Billion THB | 2.33% |
| 2015 Q2 | 2.99 Billion THB | 10.85% |
| 2015 FY | 3.27 Billion THB | 19.45% |
| 2015 Q1 | 2.69 Billion THB | -1.64% |
| 2014 FY | 2.74 Billion THB | -3.49% |
| 2014 Q4 | 2.74 Billion THB | -1.97% |
| 2014 Q3 | 2.79 Billion THB | -0.67% |
| 2014 Q2 | 2.81 Billion THB | -9.68% |
| 2014 Q1 | 3.12 Billion THB | 9.75% |
| 2013 Q4 | 2.84 Billion THB | -13.68% |
| 2013 Q3 | 3.29 Billion THB | 4.74% |
| 2013 Q2 | 3.14 Billion THB | 15.42% |
| 2013 Q1 | 2.72 Billion THB | 8.58% |
| 2013 FY | 2.84 Billion THB | 13.32% |
| 2012 FY | 2.5 Billion THB | 27.26% |
| 2012 Q4 | 2.5 Billion THB | 0.0% |
| 2011 FY | 1.97 Billion THB | 43.82% |
| 2010 FY | 1.37 Billion THB | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Mega Lifesciences Public Company Limited | 5.21 Billion THB | 0.0% |